1-(4-Chloro-2-fluorophenyl)-3,5-dimethyl-1H-pyrazole, 98%, 500mg

1-((4-Amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride, 95.0%, 25g

6-Methyl-1H-pyrrolo[3,2-c]pyridine, 95.0%, 5g

TERT-BUTYL 1,9-DIAZASPIRO[5.5]UNDECANE-1-CARBOXYLATE, 95.0%, 50mg

(Z)-TERT-BUTYL 4-(CHLORO(HYDROXYIMINO)METHYL)BENZYL(METHYL)CARBAMATE, 98%, 5g

Benzyl (2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 96%, 250mg

N-Benzyl-5-methylpyridin-2-amine, 1g

iScope IS.1159-PLPHi Biocular for phase contrast with Plan phase IOS objectives, Rackless cross table and Photo attachment (infinity - ergonomic tilting head)

(S)-2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride, 98.0%, 5mg

Ethyl 2-(2,4-difluoro-phenoxy)acetate, 97.0%, 1g

1-Ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonyl chloride, 95.0%, 250mg

Methyl tetrahydro-2H-pyran-3-carboxylate, 96.0%, 1g

3-Cyclopropylazetidin-3-ol hydrochloride, 95.0%, 5g